|
|
Exchange: |
N/A |
Security
Type: |
Common |
Shares
Out: |
125,280,000 |
Market
Cap: |
5.37(B) |
Last
Volume: |
0 |
Avg
Vol: |
0 |
52
Week Range: |
$3.16 - $47.08 |
|
Level
I Sector: |
N/A |
Level
II Sector: |
N/A |
Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
Insider 3 Months : 20.8 |
Insider 6 Months : 24.2 |
Insider 3/6 Months : 45.4 |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
|
Company Profile Corbus Pharmaceuticals Holdings is focused on the development of immune modulators that will have application in disease states spanning from immuno-oncology to fibrosis. Co.'s pipeline includes anti-integrin monoclonal antibodies that block activation of Transforming growth factor B (TGFB) and small molecules that activate or inhibit the endocannabinoid system. Co.'s pipeline includes: anti-integrin monoclonal antibodies for the treatment of cancer and fibrosis that inhibit the activation of TGFB; cannabinoid receptor type 1 inverse agonists designed to treat obesity and related metabolic diseases; and lenabasum, a synthetic, oral molecule that activates cannabinoid receptor type 2.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
550,000 |
1,582,632 |
1,582,632 |
1,633,932 |
Total Buy Value |
$23,327,560 |
$46,689,501 |
$46,689,501 |
$46,703,200 |
Total People Bought |
1 |
2 |
2 |
5 |
Total Buy Transactions |
2 |
4 |
4 |
9 |
Total Shares Sold |
0 |
0 |
0 |
0 |
Total Sell Value |
$0 |
$0 |
$0 |
$0 |
Total People Sold |
0 |
0 |
0 |
0 |
Total Sell Transactions |
0 |
0 |
0 |
0 |
End Date |
2024-02-11 |
2023-11-10 |
2023-05-12 |
2022-05-12 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Catlin Avery W |
Director |
|
2017-05-11 |
4 |
B |
$6.15 |
$30,741 |
D/D |
5,000 |
47,000 |
2.39 |
- |
|
White Barbara |
Chief Medical Officer |
|
2017-05-11 |
4 |
B |
$6.12 |
$14,905 |
D/D |
2,435 |
168,735 |
2.74 |
- |
|
Cohen Yuval |
Chief Executive Officer |
|
2017-05-11 |
4 |
B |
$6.01 |
$19,539 |
D/D |
3,250 |
56,080 |
2.81 |
- |
|
White Barbara |
Chief Medical Officer |
|
2017-03-17 |
4 |
B |
$9.49 |
$40,171 |
D/D |
4,233 |
166,300 |
2.74 |
- |
|
Cohen Yuval |
Chief Executive Officer |
|
2017-03-16 |
4 |
OE |
$1.00 |
$20,000 |
D/D |
20,000 |
52,830 |
|
- |
|
Moran Sean F. |
Chief Financial Officer |
|
2017-03-13 |
4 |
B |
$9.60 |
$19,200 |
D/D |
2,000 |
333,610 |
2.74 |
- |
|
Moran Sean F. |
Chief Financial Officer |
|
2016-12-02 |
4 |
B |
$7.20 |
$10,800 |
D/D |
1,500 |
331,610 |
2.74 |
- |
|
White Barbara |
Chief Medical Officer |
|
2016-11-22 |
4 |
B |
$7.75 |
$7,750 |
D/D |
1,000 |
162,067 |
2.74 |
- |
|
Cohen Yuval |
Chief Executive Officer |
|
2016-11-22 |
4 |
B |
$7.64 |
$10,238 |
D/D |
1,340 |
12,830 |
2.81 |
- |
|
Holmer Alan F |
Director |
|
2016-11-22 |
4 |
B |
$7.49 |
$7,490 |
D/D |
1,000 |
22,000 |
2.39 |
- |
|
Catlin Avery W |
Director |
|
2016-11-22 |
4 |
B |
$7.55 |
$15,100 |
D/D |
2,000 |
42,000 |
2.39 |
- |
|
Hochman David P |
Director |
|
2016-11-18 |
4 |
B |
$7.00 |
$69,960 |
D/D |
10,000 |
456,100 |
2.39 |
- |
|
Moran Sean F. |
Chief Financial Officer |
|
2016-09-08 |
4 |
B |
$5.12 |
$157,696 |
D/D |
30,800 |
330,110 |
2.74 |
- |
|
Moran Sean F. |
Chief Financial Officer |
|
2016-08-26 |
4 |
B |
$3.92 |
$70,168 |
D/D |
17,900 |
299,310 |
2.74 |
- |
|
Hochman David P |
Director |
|
2016-08-22 |
4 |
B |
$3.77 |
$6,786 |
D/D |
1,800 |
456,100 |
2.39 |
- |
|
Moran Sean F. |
Chief Financial Officer |
|
2016-08-18 |
4 |
B |
$3.48 |
$226,200 |
D/D |
65,000 |
281,410 |
2.74 |
- |
|
Cohen Yuval |
Chief Executive Officer |
|
2016-08-17 |
4 |
OE |
$1.00 |
$20,000 |
D/D |
20,000 |
31,490 |
|
- |
|
Moran Sean F. |
Chief Financial Officer |
|
2016-08-17 |
4 |
B |
$3.19 |
$267,832 |
D/D |
83,960 |
216,410 |
2.74 |
- |
|
White Barbara |
Chief Medical Officer |
|
2016-08-17 |
4 |
B |
$3.15 |
$119,844 |
D/D |
38,000 |
161,067 |
2.74 |
- |
|
White Barbara |
Chief Medical Officer |
|
2016-06-08 |
4 |
B |
$3.10 |
$5,999 |
D/D |
1,935 |
123,067 |
2.74 |
- |
|
Cohen Yuval |
Chief Executive Officer |
|
2016-06-06 |
4 |
B |
$3.34 |
$5,010 |
D/D |
1,500 |
11,490 |
2.81 |
- |
|
White Barbara |
Chief Medical Officer |
|
2016-06-01 |
4 |
B |
$3.52 |
$9,046 |
D/D |
2,570 |
121,132 |
2.74 |
- |
|
Moran Sean F. |
Chief Financial Officer |
|
2016-05-19 |
4 |
B |
$2.37 |
$64,583 |
D/D |
27,250 |
132,450 |
2.74 |
- |
|
Cohen Yuval |
Chief Executive Officer |
|
2016-05-18 |
4 |
B |
$2.40 |
$5,100 |
D/D |
2,125 |
9,990 |
2.81 |
- |
|
Moran Sean F. |
Chief Financial Officer |
|
2016-05-18 |
4 |
B |
$2.39 |
$71,700 |
D/D |
30,000 |
105,250 |
2.74 |
- |
|
176 Records found
|
|
Page 4 of 8 |
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Acquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|